Meryllion Resources (CSE:MYR) Closes Second Tranche of Private Placement

Vancouver, British Columbia — January 12, 2026 — Leads & Copy — Meryllion Resources Corporation (CSE: MYR) has closed a second tranche of its non-brokered private placement, issuing 5,875,000 common shares at $0.05 per share, raising gross proceeds of $293,750.

Together with the first tranche closed on December 23, 2015, the Corporation has raised a total of $575,750 pursuant to the Private Placement. The Private Placement is subject to final acceptance of the Canadian Securities Exchange.

All securities issued are subject to a four-month hold period. The funds will support exploration activities and working capital.

Meryllion CEO Richard Revelins thanked existing shareholders and welcomed new mining investors. The company plans to commence a drilling campaign at its ionic adsorption clay hosted rare earths project in northeastern Tasmania.

Revelins noted the growing focus on rare earth elements and critical metals, adding the company is looking forward to commencing drilling.

Certain insiders participated in the Second Tranche for $200,000. The issuance of Common Shares to insiders is a related-party transaction within the meaning of Multi-Lateral Instrument 61-101. Meryllion is exempt from obtaining a formal valuation and minority shareholder approval as the insiders’ participation is below 25% of the Corporation’s market capitalization.

Meryllion is an exploration stage company listed on the CSE. It has a lease and option agreement for the Makenzie gold/silver/antimony project in Nevada. Meryllion also can acquire up to 100% interest in the Westbury and Tasmanian Strategic Green Metals rare earth elements projects in Tasmania, Australia. These projects are along strike, and/or adjacent to, discoveries by ABx Group Limited.

ABx has reported that Terbium and Dysprosium concentrations in all of ABx’s rare earths resources are the highest of any ionic adsorption clay deposit in Australia and are amongst the highest globally.

For further information, please contact:

Mr. Richard Revelins
Director and Chief Executive Officer
Meryllion Resources Corporation
+1-310-405-4475
rrevelins@peregrinecorporate.com

Source: Meryllion Resources Corporation

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.